Nuwe
PrivateLast Round
Follow-on Offering
Jun 9, 2026
Total Funding Raised
$12.91M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Nuwe operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Follow-on Offering round in June 2026.
Nuwe is a business/productivity software company that has developed a gamified coding platform designed to help tech companies find talent and for developers to showcase their skills.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuwe Comparables
Compare Nuwe with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Reprieve Cardiovascular | 78% | |
| Baxter International Inc | 75% | |
| Spiralis Medical | 74% |
For institutional investors. Book with your work email.
Nuwe Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Jun 9, 2026 | ||||
| Follow-on Offering | Jun 8, 2026 | ||||
| Private Placement | Jan 30, 2026 | ||||
| Private Placement | Aug 26, 2024 | ||||
| Seed | Feb 21, 2023 | ||||
Pre Seed | Jul 8, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nuwe Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investor Growth Capital | VC Round |
| SV Health Investors | VC Round |
| Kaiser Permanente Ventures | VC Round |
| Mason Wells | VC Round |
| MPM BioImpact | VC Round |
| Demium Capital | Seed |
| FINAVES | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2026
Raised $6M in a follow-on offering.
- Jun 8, 2026
Raised $6M in a follow-on offering.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 16, 2026
Nuwellis, Inc. hired Brian Johnson as Director of Quality and Regulatory Affairs on Sep 16th '26
- partners_withAug 26, 2026
In Aug '26, Nuwellis, Inc. partners with Atrility Medical, LLC to co-promote and distribute the FDA-cleared AtriAmp device for pediatric and adult patients, starting with a six-month pilot in select United States territories.
For institutional investors. Book with your work email.
Nuwe Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nuwe's valuation, stock price, and market status.
Is Nuwe a public or private company?
Nuwe is a private company.
What is the current stock price of Nuwe?
Nuwe is a private company, so its shares have no public market price. Caplight tracks Nuwe's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nuwe worth (valuation)?
Valuation information for Nuwe is not publicly available.
Can I buy Nuwe stock?
Nuwe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nuwe's last funding round?
Nuwe's most recent funding round was Follow-on Offering on June 9, 2026.
Who are the main investors in Nuwe?
Key investors in Nuwe include SV Health Investors.
Will Nuwe IPO soon?
No public IPO plans have been announced for Nuwe.
How can I track Nuwe secondary market activity?
Caplight tracks bids, offers, and trades in Nuwe's shares on secondary markets.